# Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-study-of-nintedanib-with-or-without-pirfenidone-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Satoshi Ikeda,Akimasa Sekine,Tomohisa Baba,Terufumi Kato,Takuma Katano,Erina Tabata,Ryota Shintani,Hideaki Yamakawa,T. Oda,Ryo Okuda,Hideya Kitamura,Tae Iwasawa,Tamiko Takemura,Takashi Ogura |
| Citations | 11 |
| DOI | 10.1097/md.0000000000029232 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1097/md.0000000000029232 |
| OpenAlex ID | https://openalex.org/W4281729540 |
| PMID | 35665728 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Ryota Shintani](https://scholariq.org/researchers/ryota-shintani/)

## Paper journal

- [Medicine](https://scholariq.org/journals/medicine/)

## Paper primary topic

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)

## Paper topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.